天坛生物2025年上半年净利润同比下降12.88%

Core Viewpoint - Tian Tan Biological's performance report indicates a mixed financial outcome for the first half of 2025, with revenue growth but a decline in net profit [1] Financial Performance - The company achieved an operating income of 3.11 billion yuan, representing a year-on-year increase of 9.47% [1] - The net profit attributable to shareholders was 633 million yuan, showing a year-on-year decrease of 12.88% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 618 million yuan, reflecting a year-on-year decline of 14.56% [1]